A Study of 141W94 in Combination With Other Anti-HIV Drugs
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the steady-state pharmacokinetics of 141W94 in combination with saquinavir,
indinavir and nelfinavir after multiple oral dosing. To determine the steady-state
pharmacokinetics of saquinavir, indinavir, and nelfinavir in combination with 141W94 after
multiple oral dosing. To assess the safety and tolerability of multiple doses of 141W94 when
combined with saquinavir, indinavir and nelfinavir.